http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017360735-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac7057660ccf368f64e87c1f4212b265 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate | 2017-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3af68719c588d866e0a4d9f0bdfeacb1 |
| publicationDate | 2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2017360735-A1 |
| titleOfInvention | Ingestible emulsion matrix for delivery of creatine |
| abstract | Disclosed are compositions for improved oral delivery of creatine, methods of making such compositions, and kits comprising such compositions. In particular, the compositions are capable of dispensing a high dose of creatine in a convenient manner that does not require the consumption of liquids. The creatine is encapsulated in an emulsion matrix delivery system that contains a very low moisture level to keep the creatine in solid state, thus unexposed to moisture or acidic conditions, thereby preserving the creatine from hydrolysis, dissociation or other undesirable conversion into creatinine. n The emulsion matrix of the delivery systems provides for minimized degradation of the functional creatine during preparation of the matrix and the storage of the final delivery systems, thereby ensuring shelf stability. The use of relatively low temperatures in the preparation of the matrix, when compared to typical manufacturing procedures for other emulsions, ensures that the functional ingredients are not degraded by excessive heat. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021076926-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109907180-A |
| priorityDate | 2016-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.